Nanoparticles of cerium dioxide – an effective antiviral agent and adjuvant of biologically active molecules

Authors

DOI:

https://doi.org/10.15587/2519-8025.2018.124686

Keywords:

nanoparticles of cerium dioxide, tumor necrosis factor, interferon, herpes simples virus-1

Abstract

There was studied the influence of cerium dioxide nanoparticles on the cytokines production in the conditions of their application in the composition with interferon and as an independent drug. Applying the CDN in combination with IFN showed an increased interferon response of experimental mice compared with unmodified IFN. IFN-CDN nanobiocomplex does not increase the level of TNF production, which indirectly indicates the safety of the applying of such complex. There was studied the effect of CDN as a therapeutic agent on the cytokines production in the treatment of modeled herpes simplex virus-1 infection. It was found that CDN is able to increase IFN and TNF levels and prolong their effects. It was found that NDC is able to increase the level of IFN and FNP and prolong their effects. The application of CDN caused increasing of TNF levels and their prolonging action. There was shown the significant increasing (to three weeks) in IFN titers on the step of decreasing in TNF titers in the group, that was infected and then treated with NCD. In the non-treated group and in the aciclovir-treated animal group, IFN titers were significantly lower.The obtained results testify to the effectiveness of NDC as a modifying agent for interferon and as a promising agent for the treatment of systemic herpetic infection

Author Biographies

Olga Shydlovska, D. K. Zabolotny Institute of Microbiology and Virology of the NASU Akademika Zabolotnogo str., 154, Kyiv, Ukraine, 03680

Senior Engineer

Eugene Kharchenko, JSC «Farmak: Kyiv» Frunze str., 63, Kyiv, Ukrainе, 04080

Technician-technologist in the preparation

Ivan Osenniy, D. K. Zabolotny Institute of Microbiology and Virology of the NASU Akademika Zabolotnogo str., 154, Kyiv, Ukraine, 03680

Postgraduate student

Mykola Spivak, D. K. Zabolotny Institute of Microbiology and Virology of the NASU Akademika Zabolotnogo str., 154, Kyiv, Ukraine, 03680

Sc.D., Professor, corresponding member of National Academy of Science of Ukraine,

Alexander Shcherbakov, D. K. Zabolotny Institute of Microbiology and Virology of the NASU Akademika Zabolotnogo str., 154, Kyiv, Ukraine, 03680

PhD, Senior Researcher

Department of Problems of interferon and immunomodulators

Nadiya Zholobak, D. K. Zabolotny Institute of Microbiology and Virology of the NASU Akademika Zabolotnogo str., 154, Kyiv, Ukraine, 03680

PhD, Senior Researcher

Department of Problems of interferon and immunomodulators

References

  1. Zholobak, N. M., Olevinskaia Z. M., Spivak, N. Y., Shcherbakov, A. B., Ivanov, V. K., Usatenko, A. V. (2010). Antiviral effect of cerium dioxide nanoparticles stabilized by low-molecular polyacrylic acid. Mikrobiolohichnyi zhurnal, 72 (3), 42–47.
  2. Shcherbakov, A. B., Ivanov, V. K., Zholobak, N. M., Ivanova, O. S., Krysanov, E. Y., Baranchikov, A. E. et. al. (2011). Nanocrystalline ceria based materials–Perspectives for biomedical application. Biophysics, 56 (6), 987–1004. doi: 10.1134/s0006350911060170
  3. Ivanov, V. K., Shcherbakov, A. B., Usatenko, A. V. (2009). Structure-sensitive properties and biomedical applications of nanodispersed cerium dioxide. Russian Chemical Reviews, 78 (9), 855–871. doi: 10.1070/rc2009v078n09abeh004058
  4. Hardas, S. S., Butterfield, D. A., Sultana, R., Tseng, M. T., Dan, M., Florence, R. L. et. al. (2010). Brain Distribution and Toxicological Evaluation of a Systemically Delivered Engineered Nanoscale Ceria. Toxicological Sciences, 116 (2), 562–576. doi: 10.1093/toxsci/kfq137
  5. Shherbakov, A. B., Ivanov, V. K., Zholobak, N. M., Ivanova, O. S., Krysanov, E. Yu., Baranchikov, A. E., Tret'yakov, Yu. D. (2011). Nanokristallicheskiy dioksid tseriya: perspektivnyy material dlya biomeditsinskogo primeneniya. Biofizika, 56 (6), 995–1015.
  6. Babenko, L. P., Zholobak, N. M., Shcherbakov, A. B., Voychuk, S. I., Lazarenko, L. M., Spivak, M. Y. (2012). Antibacterial activity of cerium colloids against opportunistic microorganisms in vitro. Mikrobiolohichnyi zhurnal, 74 (3), 54–62.
  7. Jaffer, U., Wade, R. G., Gourlay, T. (2010). Cytokines in the systemic inflammatory response syndrome: a review. HSR proceedings in intensive care & cardiovascular anesthesia, 2 (3), 161–175.
  8. Muller, W. (2006). Dissecting the cytokine network. Cellular Immunology, 244 (2), 162–164. doi: 10.1016/j.cellimm.2007.01.008
  9. Simbirtsev, A. S. (2002). Tsitokiny – novaya sistema regulyatsii zashhitnykh reaktsiy organizma. Zhurnal Tsitokiny i vospalenie, 1, 9–17.
  10. Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., Farokhzad, O. (2007). Nanoparticles in Medicine: Therapeutic Applications and Developments. Clinical Pharmacology & Therapeutics, 83 (5), 761–769. doi: 10.1038/sj.clpt.6100400
  11. Kladova, O. V., Molochkova, O. V., Waltz, N. L., Kompaniets, Y. V., Grishkevich, N. L. (2016). The Value of the Interferon Inductors in the Treatment and Prevention of Respiratory Infections. Children Infections, 15 (4), 48–53. doi: 10.22627/2072-8107-2016-15-4-48-53
  12. Terrando, N., Monaco, C., Ma, D., Foxwell, B. M. J., Feldmann, M., Maze, M. (2010). Tumor necrosis factor-triggers a cytokine cascade yielding postoperative cognitive decline. Proceedings of the National Academy of Sciences, 107 (47), 20518–20522. doi: 10.1073/pnas.1014557107
  13. Mestan, J., Digel, W., Mittnacht, S., Hillen, H., Blohm, D., Moller, A. et. al. (1986). Antiviral effects of recombinant tumour necrosis factor in vitro. Nature, 323 (6091), 816–819. doi: 10.1038/323816a0
  14. Liu, Z., Guan, Y., Sun, X., Shi, L., Liang, R., Lv, X., Xin, W. (2013). HSV-1 activates NF-kappaB in mouse astrocytes and increases TNF-alpha and IL-6 expressionviaToll-like receptor 3. Neurological Research, 35 (7), 755–762. doi: 10.1179/016164113x13703372991516
  15. Ivanov, V. K., Usatenko, A. V., Shcherbakov, A. B. (2009). Antioxidant activity of nanocrystalline ceria to anthocyanins. Russian Journal of Inorganic Chemistry, 54 (10), 1522–1527. doi: 10.1134/s0036023609100039
  16. Shydlovska, O., Zholobak, N., Shcherbakov, A., Spivak, M., Ivanova-Polezhaeva, O., Ivanov, V. (2016). Response of interferon system to introduction of recombinant interferon modified with cerium dioxide nanoparticles. Bioresources and Viruses. Kyiv, 51–54.
  17. Stefanov, O. V. (Ed.) (2001). Doklinichni doslidzhennia likarskykh zasobiv. Kyiv: Avitsena, 528.
  18. Spivak, N. Ya., Nosenko, N. D., Zholobak, N. M., Shherbakov, A. B., Reznikov, A. G.,. Ivanova, O. S, Tret'yakov, Yu. D. (2013). Nanokristallicheskiy dioksid tseriya povyshaet funktsional'nuyu aktivnost' reproduktivnoy sistemy stareyushhikh samtsov krys. Nanosistemy: fizika, khimiya, matematika, 4, 72–77.
  19. Field, H. J., de Clercq, E. (1981). Effects of Oral Treatment with Acyclovir and Bromovinyldeoxyuridine on the Establishment and Maintenance of Latent Herpes Simplex Virus Infection in Mice. Journal of General Virology, 56 (2), 259–265. doi: 10.1099/0022-1317-56-2-259
  20. Wagner, R. R., Levy, A. H., Snyder, R. M., Ratcliff, G. A., Hyatt, D. F. (1963). Biologic properties of two plaque variants of vesicular stomatitis virus (Indiana serotype). The Journal of Immunology, 91 (1), 112–122.
  21. Armstrong, J. A. (1981). Cytopathic effect inhibition assay for interferon: Microculture plate assay. Methods in enzymology, 78, 381–387. doi: 10.1016/0076-6879(81)78145-x
  22. Tumor Necrosis Factor-α, Human, Recombinant Certificate of Analysis 9PIG524 (2016). Promega Corporation, 9–10.
  23. Melroe, G. T., DeLuca, N. A., Knipe, D. M. (2004). Herpes Simplex Virus 1 Has Multiple Mechanisms for Blocking Virus-Induced Interferon Production. Journal of Virology, 78 (16), 8411–8420. doi: 10.1128/jvi.78.16.8411-8420.2004

Downloads

Published

2018-02-27

How to Cite

Shydlovska, O., Kharchenko, E., Osenniy, I., Spivak, M., Shcherbakov, A., & Zholobak, N. (2018). Nanoparticles of cerium dioxide – an effective antiviral agent and adjuvant of biologically active molecules. ScienceRise: Biological Science, (1 (10), 26–30. https://doi.org/10.15587/2519-8025.2018.124686

Issue

No. 1 (10) (2018)

Section

Biological Sciences

License

Copyright (c) 2018 Olga Shydlovska, Eugene Kharchenko, Ivan Osenniy, Mykola Spivak, Alexander Shcherbakov, Nadiya Zholobak

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.